Evidence map›Paper›PMID 30337494›Full record

ArticleEMBO reports2018

The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size.

Katharina Fuchs, Yamel Cardona Gloria, Olaf-Oliver Wolz, Franziska Herster, Lokesh Sharma, Carly A Dillen, Christoph Täumer, Sabine Dickhöfer, Zsofia Bittner, Truong-Minh Dang and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Acetylation and accessibility ofCell surface (Amsterdam, Netherlands) · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Infection and immunity · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Antifungal Innate Immunity.Advances in experimental medicine and biology · 2025
    Review
  17. Loss ofFrontiers in cellular and infection microbiology · 2025
    Article
  18. Article
  19. Review
  20. PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis.The journal of allergy and clinical immunology. Global · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 9 institutions in 5 countries.

Katharina FuchsDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Yamel Cardona GloriaDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Olaf-Oliver WolzDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Franziska HersterDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Lokesh SharmaDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Microbial Pathogenesis, Center for Pulmonary Infection Research and Infection (CPIRT), New Haven, CT, USA.
Carly A DillenDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Christoph TäumerDepartment of Quantitative Proteomics and Proteome Center, University of Tübingen, Tübingen, Germany.
Sabine DickhöferDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Zsofia BittnerDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Truong-Minh DangDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Anurag SinghUniversity Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tübingen, Tübingen, Germany.
Daniel HaischerCenter for Plant Molecular Biology, University of Tübingen, Tübingen, Germany.
Maria A SchlöffelCenter for Plant Molecular Biology, University of Tübingen, Tübingen, Germany.
Kirsten J KoymansDepartment of Medical Microbiology, University Medical Center Utrecht, CX Utrecht, The Netherlands.
Tharmila SanmugananthamDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Milena KrachDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Thierry RogerInfectious Diseases Service, Lausanne University Hospital, Epalinges, Switzerland.
Didier Le RoyInfectious Diseases Service, Lausanne University Hospital, Epalinges, Switzerland.
Nadine A SchillingInstitute of Organic Chemistry, University of Tübingen, Tübingen, Germany.
Felix FrauhammerDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lloyd S MillerDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Thorsten NürnbergerCenter for Plant Molecular Biology, University of Tübingen, Tübingen, Germany.
Salomé LeibundGut-LandmannSection of Immunology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland.
Andrea A GustCenter for Plant Molecular Biology, University of Tübingen, Tübingen, Germany.ORCID 0000-0003-0466-2792
Boris MacekDepartment of Quantitative Proteomics and Proteome Center, University of Tübingen, Tübingen, Germany.
Martin FrankBiognos AB, Göteborg, Sweden.
Cécile GouttefangeasDepartment of Immunology, University of Tübingen, Tübingen, Germany.
Charles S Dela CruzDepartment of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Microbial Pathogenesis, Center for Pulmonary Infection Research and Infection (CPIRT), New Haven, CT, USA.
Dominik HartlUniversity Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tübingen, Tübingen, Germany.
Alexander Nr WeberDepartment of Immunology, University of Tübingen, Tübingen, Germany alexander.weber@uni-tuebingen.de.ORCID 0000-0002-8627-7056
University of Tübingen · DEJohns Hopkins University · USUniversity of Lausanne · CHBiognos (Sweden) · SEGerman Cancer Research Center · DERoche (Switzerland) · CHUniversity Children's Hospital Tübingen · DEUniversity Medical Center Utrecht · NLUniversity of Zurich · CH

Funding

Host-Pneumococcal Interaction in the LungR01HL126094 · NHLBI · YALE UNIVERSITY · PI DELA CRUZ, CHARLES S · 2015 to 2019
$2.1M
STAT3-mediated immunity to Staphylococcus aureus in skinR01AR069502 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ARCHER, NATHAN K. · 2016 to 2020
$1.8M
NHLBI NIH HHS R01 HL126094NIAMS NIH HHS R01 AR069502Swiss National Science Foundation 166206
6 · The paper itself

Abstract

Chitin is the second most abundant polysaccharide in nature and linked to fungal infection and asthma. However,

Indexed as

AnimalsCell WallChitinChitinasesFemaleFungiHumansHydrophobic and Hydrophilic InteractionsImmunologic FactorsInflammationLigandsLymphocytesMice, Inbred C57BLMice, KnockoutTHP-1 CellsToll-Like Receptor 1ChitinChitinasesImmunologic FactorsLigandsToll-Like Receptor 1Toll-Like Receptor 2Zymosananti‐fungal innate immunitychitininflammationN‐acetyl‐glucosaminetoll‐like receptor

Identifiers

PMID30337494
PMCPMC6280652
OpenAlexW2897131885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.